Martingale Asset Management L P Y M Abs Therapeutics, Inc. Transaction History

Martingale Asset Management L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$25.45 - $37.64 $185,886 - $274,922	-7,304 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$29.16 - $51.96 $11,664 - $20,784	-400 Reduced 5.19%	7,304 $220,000
Q4 2020 Feb 10, 2021	SELL	$37.86 - $54.26 $465,678 - $667,398	-12,300 Reduced 61.49%	7,704 $381,000
Q3 2020 Nov 12, 2020	SELL	$35.13 - $43.62 $874,737 - $1.09 Million	-24,900 Reduced 55.45%	20,004 $767,000
Q2 2020 Aug 10, 2020	BUY	$23.66 - $49.53 $1.06 Million - $2.22 Million	44,904 New	44,904 $1.94 Million

113

26.9M

5.6K

900

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $210M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.